Takeda Pharmaceutical Co., Ltd. (TAK)
16.26
-0.05
(-0.31%)
USD |
NYSE |
Jan 12, 16:00
16.26
0.00 (0.00%)
After-Hours: 18:03
Takeda Pharmaceutical Research and Development Expense (Quarterly): 1.095B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Novartis AG | 2.857B |
| Pfizer Inc. | 2.492B |
| Protagonist Therapeutics, Inc. | 40.00M |
| Nxera Pharma Co., Ltd. | 25.27M |
| PeptiDream Inc. | 7.889M |